Management of XXXX recurrence before and after liver transplantation.

@entity1 @entity82 @entity5881 @entity1560 @entity409 @entity1578 @entity157 @entity285 @entity99 @entity65
@entity5881 ( @entity5881 ) is a major cause of chronic @entity409 worldwide and can lead to @entity1560 , @entity1560 , @entity82 , @entity82 and @entity157 . The primary effective treatment for @entity1 with @entity5881 is total @entity285 abstinence, although sometimes impossible, liver transplant (LT) is the gold standard treatment for end-stage @entity5881 , which represents the second most common diagnosis among @entity1 undergoing this procedure. Liver transplant in @entity5881 has better results than those for other etiologies. The @entity285 consumption recidivism after LT is frequent and 10% to 15% of these resume heavy drinking with consequences to the new liver. The "6-month rule" of abstinence is an arbitrary threshold used in many transplant centers and has never been shown to affect survival after LT. The optimal abstinence period in pre-transplant remains unclear. The @entity1 in the pre- and post-transplant period need evaluation of a multidisciplinary team, as psychiatrist, addiction specialists, including counselling and attendance to support groups. The impact of @entity285 relapse on post-transplant outcomes is not entirely clear but is worse with continuing heavy drinking, with poorer survival beyond the fifth post-transplant year malignancy and @entity65 and not recurrent @entity1578 . @entity99 , in careful selected cases, should be transplanted and have comparable survival outcomes. Prevention of alcoholic recidivism has proved to be the most important treatment after liver transplantation.
